Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Drug Name: Isentress (raltegravir) 400mg Tablets
Company: Merck & Company, Inc.
NDA: 022145
Approval Date: 10/12/2007


Date created: February 22, 2008

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.